Clinical Trial Detail

NCT ID NCT04228042
Title Infigratinib Before Surgery for the Treatment of Upper Tract Urothelial Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

ureter transitional cell carcinoma

renal pelvis transitional cell carcinoma

Therapies

Infigratinib

Age Groups: adult senior

No variant requirements are available.